for Japanese
See more
See all
Quarterly Financial Results for the 3rd Quarter, Ended December 31, 2020 (PDF:588 KB)
Quarterly Financial Summary for the 3rd Quarter, Ended December 31, 2020 (PDF:997 KB)
Interim Report for the 97th Business Period, Ended September 30, 2020 (PDF:5.8 MB)
Quarterly Financial Results for the 2nd Quarter, Ended September 30, 2020 (PDF:870 KB)
Quarterly Financial Summary for the 2nd Quarter, Ended September 30, 2020 (PDF:764 KB)
Kaneka announced Medium-Term Management Plan (FY2020-2022) (PDF:6.0 MB)
Financial Section 2020 (PDF:807 KB)
Price revision of processed oil products
Price revision of vinyl chloride resin products
Kaneka develops technology for testing refractory respiratory infections through joint research with the National Institute of Infectious Diseases (NIID)
Kaneka releases “Watashi no Chikara (My Energy) ™ - Q10 Yogurt”
Kaneka strengthens efforts to manufacture COVID-19 DNA vaccine candidate
